CEMEC

8 scholarly publications naming this subject were located in the registry of record.

A first-in-class inhibitor of homologous recombination DNA repair counteracts tumour growth, metastasis and therapeutic resistance in pancreatic cancer, Journal of Experimental & Clinical Cancer Research, 2025. A Review of Common Medicinal Plants in Chin State, Myanmar, Natural Product Communications, 2018. N-Alkylated Monoterpene Indole Alkaloid Derivatives as Chemotherapy Adjuvants That Overcome P-glycoprotein-Mediated Multidrug Resistance in Cancer Cells, Spheroids and Patient-Derived Colorectal Cancer Organoids, Drug Design, Development and Therapy, 2026. Chemical Composition and Antifungal Activity of Essential Oils from Flowers, Leaves, Rhizomes, and Bulbs of the Wild Iraqi Kurdish Plant, Natural Product Communications, 2017. Secondary Metabolites Isolated from Species (Basidiomycota, Tricholomatacee): A Review, Natural Product Communications, 2018. Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trial, Signal Transduction and Targeted Therapy, 2023. Hemerografia, Chasqui, 2015. Effect of Opaganib on Supplemental Oxygen and Mortality in Patients with Severe SARS-CoV-2 Based upon FIO₂ Requirements, Microorganisms, 2024.

This heading is established in Gemeinsame Normdatei (GND) (116060570X). Those registers additionally record the form CEMEC GmbH.

Bibliographic registers publish measured figures for this heading: 4 language editions of the general reference literature carrying an article (Wikimedia (language editions)). A count of publications is evidence of attention, not of standing, and is given here only as a measure.

This article draws on 3 independent source lineages. Copies and mirrors of the same underlying record were collapsed into a single witness, so 3 means 3 genuinely separate publishers of record. 10 further registers were consulted and returned nothing for this heading.